Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX save search
DADA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dada Nexus Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-01-18 (Crawled : 09:00) - prnewswire.com
CMI | $293.75 0.36% 280K
|
Producer Manufacturing
|
| O: -0.13%
H: 0.59%
C: 0.18%
DADA | News | $1.985 6.72% 780K
|
Technology Services
|
| O: 1.33%
H: 21.05%
C: 18.42%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.19%
H: 0.2%
C: -0.27%
AC Immune Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 12:00) - globenewswire.com
LLY | News | $735.1 -1.42% 1.2M
|
Health Technology
|
| O: 0.0%
H: 5.72%
C: 2.53%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 2.61%
H: 20.19%
C: 14.8%
ACIU | $2.37 -0.42% 86K
|
Health Technology
|
| O: -1.54%
H: 4.56%
C: 0.0%
financial results results
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -1.98%
H: 0.73%
C: -1.19%
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.72%
C: -0.36%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 2.61%
H: 20.19%
C: 14.8%
acquisition therapy
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
Published: 2021-08-09 (Crawled : 12:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.97%
H: 0.23%
C: -0.18%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 3.06%
H: 12.65%
C: 9.55%
financial results results
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.265 -4.8% 2M
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
financial results report results tiona
Monoclonal Antibodies Clinical Trial Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-05 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
OMER | $3.075 -0.49% 140K
|
Health Technology
|
| O: 0.54%
H: 4.66%
C: -2.55%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.77%
H: 1.52%
C: 1.33%
AGEN A | $7.34 13.62% 840K
|
Health Technology
|
| O: 0.63%
H: 11.18%
C: 7.45%
companies pipeline trial
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.07 1.91% 260K
|
Professional, Scientific, and T...
|
| O: 4.69%
H: 4.55%
C: -2.99%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: 2.92%
H: 1.06%
C: -3.05%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
AZN | News | $71.26 0.58% 3.8M
|
Health Technology
|
| O: 1.07%
H: 0.1%
C: -0.94%
AGEN A | $7.34 13.62% 840K
|
Health Technology
|
| O: 3.13%
H: 11.02%
C: 7.11%
protein growth market
RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published: 2023-07-27 (Crawled : 08:00) - prnewswire.com
RNAZ | $0.452 -1.72% 74K
|
Professional, Scientific, and T...
|
| O: 2.57%
H: 3.43%
C: 0.47%
TMO | News | $576.13 0.27% 1.1M
|
Health Technology
|
| O: 0.17%
H: 0.35%
C: -2.67%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.7%
H: 0.12%
C: -0.76%
SLN | $22.44 -0.31% 35K
|
Health Technology
|
| O: 2.61%
H: 0.27%
C: -2.18%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
BNTC | $6.96 1.46% 25K
|
Health Technology
|
| O: -8.92%
H: 9.49%
C: 0.59%
drug report market
BIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioVie Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-01-23 (Crawled : 20:00) - prnewswire.com
CMI | $293.75 0.36% 280K
|
Producer Manufacturing
|
| O: 0.84%
H: 0.0%
C: -1.0%
BIVI | $0.5087 3.44% 750K
|
Health Technology
|
| O: 2.15%
H: 8.42%
C: -4.21%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.51%
H: 0.33%
C: -1.88%
EAF INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 25, 2024 in Securities Fraud Class Action Lawsuit Filed against GrafTech International Ltd.
Published: 2024-03-12 (Crawled : 01:00) - prnewswire.com
EAF | $1.625 3.5% 1.4M
|
Producer Manufacturing
|
| O: -0.56%
H: 8.38%
C: 4.47%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
international deadline
Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Published: 2021-11-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: -0.23%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -1.72%
H: 1.02%
C: 0.49%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 7.04%
H: 8.12%
C: 7.96%
covid vaccine phase 3 trial
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Published: 2022-03-08 (Crawled : 13:30) - globenewswire.com
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -7.15%
H: 7.89%
C: 3.44%
libtayo collaboration
Biotechs Step Up Development Activities as U.S. Government Prioritizes Availability Of COVID-19 Vaccines
Published: 2021-03-15 (Crawled : 13:00) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 0.2%
H: 1.2%
C: 1.14%
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: 0.09%
H: 0.57%
C: 0.42%
NVAX | $4.14 -1.19% 1.4M
|
Health Technology
|
| O: 0.27%
H: 7.58%
C: 6.95%
MRNA | News S | $108.57 0.63% 2.4M
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.69%
H: 4.0%
C: 3.74%
covid biotech vaccine iot covid-19
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
Published: 2022-06-23 (Crawled : 11:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.0%
H: 7.45%
C: 6.98%
vaccine mrna construction africa
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
Published: 2023-10-23 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
day report innovation update series financial results
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.19%
H: 7.03%
C: 5.71%
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.